Octapharma AB Octapharma Pharmazeutika Produktionsgesellschaft GmbH (OPG) Octapharma S.A.S.
PolandAll drugs from this manufacturer
-
The medicinal product is used for the treatment and prevention of bleeding in patients with haemophilia A, which results from a deficiency of coagulation factor VIII in the blood.
Dosage form: powder and solvent for solution for injection and infusion
Active substance Dosage human coagulation factor viii 50 j.m./1 ml ATC: B02BD02
-
The medicine is used for the treatment and prevention of bleeding in people with haemophilia A, which results from a congenital deficiency of coagulation factor VIII in the blood.
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage human coagulation factor viii 100 j.m./1 ml ATC: B02BD02